Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated trastuzumab (Herceptin) in combination with a taxane in patients with HER2-positive breast cancer who relapsed after prior Hercepti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Taxane (paclitaxel or docetaxel)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2016-12-29